×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
HemoSonics' Quantra® Hemostasis System
Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot
Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board
BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®
Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)
Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time
UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.
nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.
Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research
FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.
Featured Press Releases
NS Pharma announces a leadership change, appointing new commercial head to drive strategic growth and innovation
Moleculin's AML treatment gets EMA's Orphan Drug Designation
18 Apr 2024
Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage
...
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study
Fast Company recognizes Bruin Biometrics as a top 10 innovative medical device maker
Fast Company recognizes Bruin Biometrics as a top 10 innovative medical device maker
By
Bruin Biometrics, LLC
Bruin Biometrics, LLC
25 Mar 2025
Medline to launch a synthetic ligament augmentation implant.
By
Medline Industries, LP
Medline Industries, LP
24 Mar 2025
Pint Pharma secures ANVISA approval for BESREMi® to treat Polycythemia Vera
By
Pint Pharma
Pint Pharma
24 Mar 2025
Secretome Therapeutics' STM-01, a neonatal cardiac progenitor cell therapy for HFpEF, receives FDA Fast Track designation
By
Secretome Therapeutics
Secretome Therapeutics
23 Mar 2025
Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate
By
PHC Corporation
PHC Corporation
20 Mar 2025
Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience
By
Niagen Bioscience
Niagen Bioscience
19 Mar 2025
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
PharmAbcine's Phase 1 Trial of PMC-403 for Neovascular Age-Related Macular Degeneration Advances to Single-Dose (4mg) and Multiple-Dose (3mg)
By
PharmAbcine
Jul 02
Trailblazing 3D human liver models yield accurate MASH phenotype
By
Viscient Bio, Inc.
Jan 24
Bavarian Nordic gets a HERA order and announces a major vaccine donation for the Mpox outbreak in Africa
By
Bavarian Nordic A/S
Aug 13
March
2025
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
